Miranda Davies

Chief Medical Officer
Drug Safety Research Unit, Southampton, UK
Southampton, United Kingdom

Disclosure information not submitted.

Presentation(s):

• Case Series Analysis of Thromboembolic Events (Arterial and Venous) in Vaccinees Following AZD1222 (ChAdOx1 nCoV-19): Results from a UK Post-authorisation Active Surveillance Study

  Wednesday, August 28, 2024
  1:45 PM – 2:00 PM CEST